干扰MDM2减轻高血压的血管内皮功能障碍,部分是通过阻断Notch1/NLRP3炎症酶通路
Rongyan Sun1, Yubo Zhou2, Jiao Liang1
1Department of General Practice, The First People's Hospital of Qujing City, Qujing, Yunnan 655000, China.
在高血压中击败鼠类双分钟2 (MDM2) 降低了血管损伤和内皮功能障碍. 这种保护作用通过抑制Notch1信号和NLRP3炎症酶激活来介导,提供了潜在的治疗标.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 高血压是一种严重的疾病,其特点是血管内皮功能障碍.
- 鼠双分钟2 (MDM2) 正在研究其在高血压和相关血管损伤中的作用.
研究的目的:
- 探索MDM2在高血压中的调节作用.
- 在高血压模型中研究MDM2对血管损伤的影响.
主要方法:
- 建立了使用血管素II (AngII) 输液的高血压小鼠模型.
- 在体外使用AngII刺激的人类静脉内皮细胞 (HUVECs).
- 评估了MDM2对血压,大动脉组织学,血管功能和内皮细胞标志物 (ZO-1,p-eNOS) 的淘汰效应.
- 研究了Notch1信号传递和NLRP3炎症酶通路的参与.
主要成果:
- 在高血压小鼠中,MDM2被上调.
- 降低MDM2 knockdown降低了血压,大动脉损伤,并改善了血管放松.
- 在HUVECs中,MDM2倒置抑制了内皮细胞亡和功能障碍.
- 在MDM2中,MDM2 knockdown禁用了Notch1信号和NLRP3炎症酶,在Notch1激活时观察到部分恢复.
结论:
- 在高血压中,MDM2倒置减轻了血管内皮功能障碍.
- 抑制MDM2的保护作用与抑制Notch1和NLRP3炎症酶激活有关.
更多相关视频
09:32Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model
Published on: February 23, 2020
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
相关概念视频
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Action of Calcium Channel Blockers
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Regulation of Angiogenesis and Blood Supply
Antihypertensive Drugs: Angiotensin II Receptor Blockers
